DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Pancreatic cancer	R-HSA-9700206	map05212	SC-560	643606	drug-path
Prostate cancer	R-HSA-2990872	map05215	SC-560	643606	drug-path
Bladder cancer	R-HSA-9700206	map05219	SC-560	643606	drug-path
mTOR signaling pathway	R-HSA-165662	map04150	SC-560	643606	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	SC-560	643606	drug-path
Endometrial cancer	R-HSA-2077421	map05213	SC-560	643606	drug-path
Chronic myeloid leukemia	R-HSA-9680350	map05220	SC-560	643606	drug-path
Pathways in cancer	R-HSA-9824443	map05200	mefexamide	4045	drug-path
Olfactory transduction	R-HSA-9751605	map04740	mefexamide	4045	drug-path
Focal adhesion	R-HSA-354113	map04510	mefexamide	4045	drug-path
Phosphatidylinositol signaling system	R-HSA-1280215	map04070	mefexamide	4045	drug-path
Olfactory transduction	R-HSA-9751605	map04740	hydrastinine	3638	drug-path
Tight junction	R-HSA-2134514	map04530	hydrastinine	3638	drug-path
Epithelial cell signaling in Helicobacter pylori infection	0	map05120	hydrastinine	3638	drug-path
Gap junction	R-HSA-190861	map04540	hydrastinine	3638	drug-path
RNA polymerase	R-HSA-73864	map03020	hydrastinine	3638	drug-path
Alzheimer's disease	R-HSA-1643685	0	metampicillin	6713928	drug-path
T cell receptor signaling pathway	R-HSA-983705	map04660	metampicillin	6713928	drug-path
Olfactory transduction	R-HSA-9751605	map04740	metampicillin	6713928	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	metampicillin	6713928	drug-path